National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Testicular Cancer Screening (PDQ®)
Patient VersionHealth Professional VersionLast Modified: 04/03/2008



Purpose of This PDQ Summary







Summary of Evidence






Significance






Evidence of Benefit






Get More Information From NCI






Changes To This Summary (04/03/2008)






Questions or Comments About This Summary






More Information



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Summary of Evidence

Benefits
Harms

Note: Separate PDQ summaries on Testicular Cancer Treatment and Levels of Evidence for Cancer Screening and Prevention Studies are also available.

Benefits

Based on fair evidence, screening for testicular cancer would not result in an appreciable decrease in mortality, in part because therapy at each stage is so effective.

Harms

Based on fair evidence, screening for testicular cancer would result in unnecessary diagnostic procedures with attendant morbidity.

Description of the Evidence

  • Study Design: Opinions of respected authorities based on clinical experience, descriptive studies, or reports of expert committees.
  • Internal Validity: Not applicable.
  • Consistency: Not applicable.
  • Direction and Magnitude of Effect: Fair evidence of no reduction in mortality; good evidence for rare but serious harms.

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov